Clinical Trial Update: Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating OMTX705 as a monotherapy and in combination with an anti-PD-1 therapy in patients with advanced solid tumors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Anti-PD-1 inhibitor
• OMTX705 (OMTX705)

Snippet

Sponsor: Oncomatryx Biopharma S.L. | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING